Atlanta Consulting Group Advisors LLC Has $1.77 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Atlanta Consulting Group Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 43.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,025 shares of the healthcare conglomerate's stock after purchasing an additional 919 shares during the quarter. Atlanta Consulting Group Advisors LLC's holdings in UnitedHealth Group were worth $1,769,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. GoalVest Advisory LLC grew its position in UnitedHealth Group by 4.0% in the third quarter. GoalVest Advisory LLC now owns 3,248 shares of the healthcare conglomerate's stock worth $1,899,000 after acquiring an additional 124 shares during the period. BCGM Wealth Management LLC raised its stake in shares of UnitedHealth Group by 2.8% in the third quarter. BCGM Wealth Management LLC now owns 3,715 shares of the healthcare conglomerate's stock valued at $2,172,000 after acquiring an additional 100 shares in the last quarter. Schear Investment Advisers LLC raised its stake in UnitedHealth Group by 12.5% in the third quarter. Schear Investment Advisers LLC now owns 4,896 shares of the healthcare conglomerate's stock valued at $2,863,000 after buying an additional 544 shares in the last quarter. Turtle Creek Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 13.7% during the third quarter. Turtle Creek Wealth Advisors LLC now owns 2,139 shares of the healthcare conglomerate's stock worth $1,251,000 after purchasing an additional 258 shares in the last quarter. Finally, Evergreen Wealth Management LLC increased its position in shares of UnitedHealth Group by 28.4% during the third quarter. Evergreen Wealth Management LLC now owns 2,609 shares of the healthcare conglomerate's stock worth $1,525,000 after purchasing an additional 577 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of analyst reports. HSBC lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, October 17th. Cantor Fitzgerald boosted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a report on Wednesday, October 16th. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Thursday, October 17th. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an "overweight" rating and a $675.00 price target for the company. Finally, Barclays decreased their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating for the company in a research report on Tuesday, October 22nd. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $615.53.

UnitedHealth Group Stock Down 0.2 %

NYSE:UNH traded down $0.92 during trading hours on Friday, hitting $592.23. 3,423,919 shares of the stock traded hands, compared to its average volume of 3,119,612. The firm has a market cap of $545.02 billion, a price-to-earnings ratio of 38.58, a PEG ratio of 1.74 and a beta of 0.58. The firm has a 50 day moving average price of $582.84 and a 200 day moving average price of $549.52. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the company earned $6.56 earnings per share. UnitedHealth Group's quarterly revenue was up 9.2% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.